rs771740634
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 8P and 4B. PVS1BS2
The NM_001270458.2(MAOA):c.3G>A(p.Met1?) variant causes a start lost change. The variant allele was found at a frequency of 0.00000513 in 1,168,470 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000018 ( 0 hom., 0 hem., cov: 23)
Exomes 𝑓: 0.0000038 ( 0 hom. 2 hem. )
Consequence
MAOA
NM_001270458.2 start_lost
NM_001270458.2 start_lost
Scores
3
13
1
Clinical Significance
Conservation
PhyloP100: 4.87
Genes affected
MAOA (HGNC:6833): (monoamine oxidase A) This gene is one of two neighboring gene family members that encode mitochondrial enzymes which catalyze the oxidative deamination of amines, such as dopamine, norepinephrine, and serotonin. Mutation of this gene results in Brunner syndrome. This gene has also been associated with a variety of other psychiatric disorders, including antisocial behavior. Alternatively spliced transcript variants encoding multiple isoforms have been observed. [provided by RefSeq, Jul 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 4 ACMG points.
PVS1
Start lost variant, no new inframe start found.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAOA | NM_000240.4 | c.402G>A | p.Met134Ile | missense_variant | 4/15 | ENST00000338702.4 | NP_000231.1 | |
MAOA | NM_001270458.2 | c.3G>A | p.Met1? | start_lost | 5/16 | NP_001257387.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAOA | ENST00000338702.4 | c.402G>A | p.Met134Ile | missense_variant | 4/15 | 1 | NM_000240.4 | ENSP00000340684.3 |
Frequencies
GnomAD3 genomes AF: 0.0000179 AC: 2AN: 111573Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33757
GnomAD3 genomes
AF:
AC:
2
AN:
111573
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33757
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183090Hom.: 0 AF XY: 0.0000148 AC XY: 1AN XY: 67628
GnomAD3 exomes
AF:
AC:
2
AN:
183090
Hom.:
AF XY:
AC XY:
1
AN XY:
67628
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000378 AC: 4AN: 1056897Hom.: 0 Cov.: 26 AF XY: 0.00000613 AC XY: 2AN XY: 326109
GnomAD4 exome
AF:
AC:
4
AN:
1056897
Hom.:
Cov.:
26
AF XY:
AC XY:
2
AN XY:
326109
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000179 AC: 2AN: 111573Hom.: 0 Cov.: 23 AF XY: 0.00 AC XY: 0AN XY: 33757
GnomAD4 genome
AF:
AC:
2
AN:
111573
Hom.:
Cov.:
23
AF XY:
AC XY:
0
AN XY:
33757
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
2
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 20, 2024 | The c.402G>A (p.M134I) alteration is located in exon 4 (coding exon 4) of the MAOA gene. This alteration results from a G to A substitution at nucleotide position 402, causing the methionine (M) at amino acid position 134 to be replaced by an isoleucine (I). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Brunner syndrome Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jun 20, 2018 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be tolerated, but these predictions have not been confirmed by published functional studies and their clinical significance is uncertain. This variant has not been reported in the literature in individuals with MAOA-related disease. This variant is present in population databases (rs771740634, ExAC 0.004%). This sequence change replaces methionine with isoleucine at codon 134 of the MAOA protein (p.Met134Ile). The methionine residue is moderately conserved and there is a small physicochemical difference between methionine and isoleucine. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Pathogenic
D
BayesDel_noAF
Uncertain
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
.;D
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
D;D
M_CAP
Pathogenic
D
MetaRNN
Uncertain
D;T
MetaSVM
Uncertain
D
MutationAssessor
Uncertain
.;M
PrimateAI
Uncertain
T
PROVEAN
Uncertain
D;D
REVEL
Uncertain
Sift
Uncertain
D;D
Sift4G
Uncertain
D;D
Polyphen
0.60
.;P
Vest4
MutPred
0.64
.;Loss of disorder (P = 0.1186);
MVP
MPC
1.1
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at